Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Acerus Pharmaceuticals Corporation (ASPCF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.85000.0000 (0.00%)
At close: 12:01PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/3/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
6.55M10.20M17.03M55.22M31.21M41.51M
Enterprise Value
49.66M49.27M48.80M76.67M45.95M52.07M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.153.576.49N/AN/AN/A
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
16.3563.9965.2398.0462.2788.70
Enterprise Value/EBITDA
-2.10-19.05-7.37-14.14-5.10-13.67

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 3-78.75%
S&P500 52-Week Change 3-14.94%
52 Week High 38.0000
52 Week Low 30.0200
50-Day Moving Average 31.1798
200-Day Moving Average 33.1298

Share Statistics

Avg Vol (3 month) 367
Avg Vol (10 day) 320
Shares Outstanding 57.71M
Implied Shares Outstanding 6N/A
Float 8659.94k
% Held by Insiders 191.41%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:200
Last Split Date 3Apr 28, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-840.78%

Management Effectiveness

Return on Assets (ttm)-54.10%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)3.04M
Revenue Per Share (ttm)0.40
Quarterly Revenue Growth (yoy)31.20%
Gross Profit (ttm)1M
EBITDA -25.32M
Net Income Avi to Common (ttm)-28.08M
Diluted EPS (ttm)-3.6340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.02M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)46.13M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.67
Book Value Per Share (mrq)-1.80

Cash Flow Statement

Operating Cash Flow (ttm)-25.84M
Levered Free Cash Flow (ttm)-14.14M
Advertisement
Advertisement